News BMS files Opdivo in post-surgery setting Opdivo performed better than BMS' Yervoy in clinical trial.
News Biofrontera mulls US IPO to fund skin cancer drug German biotech Biofrontera is considering a US stock market listing to fund development and marketing of a skin cancer drug.
News Merck KGaA and Pfizer break into cancer immunotherapy Merck KGaA and Pfizer have got the fourth checkpoint inhibitor to market after the US regulator approved their avelumab for a rare form of skin cancer.
News AI on par with dermatologists at diagnosing skin cancer Technology could inspire a smartphone-based skin cancer diagnostic app.
Roche Roche muscling into melanoma with Tecentriq Swiss pharma looking to combine immunotherapy with already marketed drugs.
Articles Digital health round-up - skin cancer, vocal biomarkers and ... A round-up of this week's top digital healthcare news. Marco Ricci reports.
News Gene therapy firm Kate Tx snapped up by Novartis for $1.1bn Novartis buys gene therapy specialist Kate Therapeutics for $1.1 billion, adding an early-stage rival to Sarepta's muscular dystrophy therapy Elevidys
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
